• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

MMWR Morb Mortal Wkly Rep . Influenza Activity and Composition of the 2022-23 Influenza Vaccine - United States, 2021-22 Season

tetano

Editor, Senior Moderator
MMWR Morb Mortal Wkly Rep


. 2022 Jul 22;71(29):913-919.
doi: 10.15585/mmwr.mm7129a1.
Influenza Activity and Composition of the 2022-23 Influenza Vaccine - United States, 2021-22 Season


Angiezel Merced-Morales[SUP] 1 [/SUP], Peter Daly[SUP] 1 [/SUP], Anwar Isa Abd Elal[SUP] 1 [/SUP], Noreen Ajayi[SUP] 1 [/SUP], Ekow Annan[SUP] 1 [/SUP], Alicia Budd[SUP] 1 [/SUP], John Barnes[SUP] 1 [/SUP], Arielle Colon[SUP] 1 [/SUP], Charisse N Cummings[SUP] 1 [/SUP], A Danielle Iuliano[SUP] 1 [/SUP], Juliana DaSilva[SUP] 1 [/SUP], Nick Dempster[SUP] 1 [/SUP], Shikha Garg[SUP] 1 [/SUP], Larisa Gubareva[SUP] 1 [/SUP], Daneisha Hawkins[SUP] 1 [/SUP], Amanda Howa[SUP] 1 [/SUP], Stacy Huang[SUP] 1 [/SUP], Marie Kirby[SUP] 1 [/SUP], Krista Kniss[SUP] 1 [/SUP], Rebecca Kondor[SUP] 1 [/SUP], Jimma Liddell[SUP] 1 [/SUP], Shunte Moon[SUP] 1 [/SUP], Ha T Nguyen[SUP] 1 [/SUP], Alissa O'Halloran[SUP] 1 [/SUP], Catherine Smith[SUP] 1 [/SUP], Thomas Stark[SUP] 1 [/SUP], Katie Tastad[SUP] 1 [/SUP], Dawud Ujamaa[SUP] 1 [/SUP], Dave E Wentworth[SUP] 1 [/SUP], Alicia M Fry[SUP] 1 [/SUP], Vivien G Dugan[SUP] 1 [/SUP], Lynnette Brammer[SUP] 1 [/SUP]



Affiliations

Abstract

Before the emergence of SARS-CoV-2, the virus that causes COVID-19, influenza activity in the United States typically began to increase in the fall and peaked in February. During the 2021-22 season, influenza activity began to increase in November and remained elevated until mid-June, featuring two distinct waves, with A(H3N2) viruses predominating for the entire season. This report summarizes influenza activity during October 3, 2021-June 11, 2022, in the United States and describes the composition of the Northern Hemisphere 2022-23 influenza vaccine. Although influenza activity is decreasing and circulation during summer is typically low, remaining vigilant for influenza infections, performing testing for seasonal influenza viruses, and monitoring for novel influenza A virus infections are important. An outbreak of highly pathogenic avian influenza A(H5N1) is ongoing; health care providers and persons with exposure to sick or infected birds should remain vigilant for onset of symptoms consistent with influenza. Receiving a seasonal influenza vaccine each year remains the best way to protect against seasonal influenza and its potentially severe consequences.
 
Back
Top Bottom